The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Open accessAbstract
Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by progressive accumulation of disability. Epidemiological studies have shown that genetic factors are primarily responsible for the substantially increased frequency of the disease seen in the relatives of affected individuals, and systematic attempts to identify linkage in multiplex families have confirmed that variation within the major histocompatibility complex (MHC) exerts the greatest individual effect on risk. Modestly powered genome-wide association studies (GWAS) have enabled more than 20 additional risk loci to be identified and have shown that multiple variants exerting modest individual effects have a key role in disease susceptibility. Most of the genetic architecture underlying susceptibility to the disease remains to be defined and is anticipated to require the analysis of sample sizes that are beyond the numbers currently available to individual research groups. In a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, we have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci. Within the MHC we have refined the identity of the HLA-DRB1 risk alleles and confirmed that variation in the HLA-A gene underlies the independent protective effect attributable to the class I region. Immunologically relevant genes are significantly overrepresented among those mapping close to the identified loci and particularly implicate T-helper-cell differentiation in the pathogenesis of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The role of the adaptive arm of the immune system, particularly its CD4+ T cell component has become clearer, with multiple different T cell subsets being implicated.(4)”
From Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the role of B cells, dendritic cells and natural killer cells has emerged more clearly, broadening the prior narrative of T cell dysregulation that emerged from earlier studies.(4)”
From Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“published efforts to systematically interrogate severity have, thus far, only involved modest numbers of cases, and unanimously fall short of identifying any convincingly associated genetic variants5,10,11.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“refinement of the associations in the HLA region showed that just four variants are sufficient to account for the risk previously attributed to extended haplotype alleles spanning hundreds of kilobases (kb) and many tens of genes.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the GWAS enrichment studies all point to risk being mediated by gene regulation in CD4+ T cells43”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have explored the genetic basis of clinical course, age of onset and severity, although no genome‐wide significant associations have been discovered.36, 37, 43, 74, 75, 76, 77”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although these risk variants have been found to reduce the age at onset5, it is notable that they do not appear to have any impact on disease severity6.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“A further expansion of the IMSGC resulted in a collaborative GWAS of 9772 cases and 17 376 controls, again of European descent, in 2011.43 This study replicated 23 of 26 previously identified associations and identified 29 novel risk loci.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“it became evident that these loci are strongly enriched for genes acting in T‐cell activation and proliferation pathways.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,699
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162 · cited 1×
“However, even use of all seven top principal components that captured genome-wide effects in our data resulted in an unacceptably high genomic inflation: for example, the genomic control facto”
Variance component model to account for sample structure in genome-wide association studies
Kang, H. M., Sul, J. H., Service, S. K., Zaitlen, N. A., Kong, S.-Y., Freimer, N. B., Sabatti, C., & Eskin, E. (2010) · Nature Genetics · doi:10.1038/ng.548 · Cited by 2,817
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Strange, A., Spencer, C. C. A., Band, G., Bellenguez, C., Freeman, C., Pirinen, M., Rautanen, A., Su, Z., Donnelly, P., Capon, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.694 · Cited by 1,056
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) · Nature Genetics · doi:10.1038/ng.396 · Cited by 550
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn388 · Cited by 476
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,003
The role of the immune system in posttraumatic stress disorder
Katrinli, Ş., Oliveira, N. C. D. S., Felger, J. C., Michopoulos, V., & Smith, A. K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02094-7 · Cited by 201
Genetics of Multiple Sclerosis: An Overview and New DirectionsPreprint
Patsopoulos, N. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028951 · Cited by 188
Modeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 184
Tao, C., Simpson, S., Taylor, B. V., Blizzard, L., Lucas, R. M., Ponsonby, A., Broadley, S., AusLong/Ausimmune Investigators Group, & van der Mei, I. A. F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00418 · Cited by 175
Ditoro, D. F., Harbour, S. N., Bando, J. K., Benavides, G. A., Witte, S. J., Laufer, V. A., Moseley, C. E., Singer, J. R., Frey, B. F., Turner, H., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.013 · Cited by 178
The Anglo-Saxon migration and the formation of the early English gene pool
Gretzinger, J., Sayer, D., Justeau, P., Altena, E., Pala, M., Dulias, K., Edwards, C. J., Jodoin, S., Lacher, L., Sabin, S. J., et al. (2022) · Nature · doi:10.1038/s41586-022-05247-2 · Cited by 179
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells
Healy, L. M., Perron, G., Won, S.-Y., Michell-Robinson, M. A., Rezk, A., Ludwin, S. K., Moore, C. S., Hall, J. A., Bar-Or, A., & Antel, J. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502562 · Cited by 174
van de Bunt, M., Fox, J. E. M., Dai, X.-Q., Barrett, A., Grey, C. L., Li, L., Bennett, A. J., Johnson, P. R. V., Rajotte, R. V., Gaulton, K. J., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005694 · Cited by 181
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation
Andlauer, T. F. M., Buck, D., Antony, G., Bayas, A., Bechmann, L., Berthele, A., Chan, A., Gasperi, C., Gold, R., Graetz, C., et al. (2016) · Science Advances · doi:10.1126/sciadv.1501678 · Cited by 178
van Nierop, G. P., van Luijn, M. M., Michels, S. S., Melief, M.-J., Janssen, M., Langerak, A. W., Ouwendijk, W. J. D., Hintzen, R. Q., & Verjans, G. M. G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1744-4 · Cited by 174
Beaumont, R. N., Warrington, N. M., Cavadino, A., Tyrrell, J., Nodzenski, M., Horikoshi, M., Geller, F., Myhre, R., Richmond, R. C., Paternoster, L., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx429 · Cited by 176
Himmelstein, D. S., & Baranzini, S. E. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004259 · Cited by 172
Effect of Smoking Cessation on Multiple Sclerosis Prognosis
Ramanujam, R., Hedström, A. K., Manouchehrinia, A., Alfredsson, L. S., Olsson, T. P., Bottai, M., & Hillert, J. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1788 · Cited by 172
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
Mitrovič, M., Patsopoulos, N. A., Beecham, A. H., Dankowski, T., Goris, A., Dubois, B., D'hooghe, M. B., Lemmens, R., Damme, P. V., Søndergaard, H. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.049 · Cited by 179
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
Hartmann, F. J., Khademi, M., Aram, J., Ammann, S., Kockum, I. S., Constantinescu, C. S., Gran, B., Piehl, F., Olsson, T. P., Deak, L. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6056 · Cited by 186
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus
Su, Z., Gay, L. J., Strange, A., Palles, C., Band, G., Whiteman, D. C., Lescai, F., Langford, C., Nanji, M. S., Edkins, S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2408 · Cited by 172
Perriot, S., Mathias, A., Perriard, G., Canales, M., Jonkmans, N., Merienne, N., Meunier, C., El Kassar, L., Perrier, A. L., Laplaud, D.-A., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.09.015 · Cited by 171
Vitamin D and the nervous system
Bivona, G., Gambino, C. M., Iacolino, G., & Ciaccio, M. (2019) · Neurological Research · doi:10.1080/01616412.2019.1622872 · Cited by 169
Bach2 maintains T cells in a naive state by suppressing effector memory-related genes
Tsukumo, S.-I., Unno, M., Muto, A., Takeuchi, A., Kometani, K., Kurosaki, T., Igarashi, K., & Saito, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306691110 · Cited by 168
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic
Mi, S., Pepinsky, R. B., & Cadavid, D. (2013) · CNS Drugs · doi:10.1007/s40263-013-0068-8 · Cited by 168
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
Mayne, K., White, J. A., McMurran, C. E., Rivera, F. J., & de la Fuente, A. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572090 · Cited by 167
Advances in the immunopathogenesis of multiple sclerosis
Yadav, S. K., Mindur, J. E., Ito, K., & Dhib-Jalbut, S. S. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000205 · Cited by 173
Promotion and prevention of autoimmune disease by CD8+ T cells
Gravano, D. M., & Hoyer, K. K. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.004 · Cited by 166
‘Metabolically healthy obesity’: Origins and implications
Denis, G. V., & Obin, M. S. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.004 · Cited by 176
Specific peripheral B cell tolerance defects in patients with multiple sclerosis
Kinnunen, T. T., Chamberlain, N., Morbach, H., Cantaert, T., Lynch, M. T., Preston‐Hurlburt, P., Herold, K. C., Hafler, D. A., O’Connor, K. C., & Meffre, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68775 · Cited by 170
Multiple sclerosis and the role of immune cells
Høglund, R. A. (2014) · World Journal of Experimental Medicine · doi:10.5493/wjem.v4.i3.27 · Cited by 168
Dissection of genetic factors associated with amyotrophic lateral sclerosis
Leblond, C. S., Kaneb, H., Dion, P. A., & Rouleau, G. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.013 · Cited by 175
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats
Baud, A., López-Aumatell, R., Mott, R., Flint, J., Hermsen, R., Guryev, V., Lansu, N. R., Toonen, P. W., Ruzius, F. P., de Bruijn, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2644 · Cited by 173
Baranzini, S. E., Khankhanian, P., Patsopoulos, N. A., Li, M., Stankovich, J. M., Cotsapas, C. J., Søndergaard, H. B., Ban, M., Barizzone, N., Bergamaschi, L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.019 · Cited by 162
Alcina, A., Abad‐Grau, M. M., Fedetz, M., Izquierdo, G., Lucas, M., Fernández, Ó., Ndagire, D., Catalá-Rabasa, A., Ruiz, A., Gayán, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029819 · Cited by 174
Zhang, X., Tao, Y., Chopra, M., Ahn, M., Marcus, K. L., Choudhary, N. R., Hongtu Zhu, B., & Markovic‐Plese, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301926 · Cited by 162
Emerging patterns of genetic overlap across autoimmune disorders
Miceli‐Richard, C., & Criswell, L. A. (2012) · Genome Medicine · doi:10.1186/gm305 · Cited by 160
Multiple sclerosis, a treatable disease
Doshi, A., & Chataway, J. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-6-530 · Cited by 159
Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases
Chen, M. L., & Sundrud, M. S. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000714 · Cited by 162
Stevanović, M. J., Drakulić, D., Lazic, A., Ninković, D. S., Schwirtlich, M., & Mojsin, M. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.654031 · Cited by 168
Biomarkers in Multiple SclerosisPreprint
Paul, A., Comabella, M., & Gandhi, R. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029058 · Cited by 170
Bell, C. G., Gao, F., Yuan, W., Roos, L., Acton, R., Xia, Y., Bell, J. T., Ward, K. J., Mangino, M., Hysi, P. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01586-1 · Cited by 157
Genome-wide association study identifies multiple loci associated with bladder cancer risk
Figueroa, J. D., Ye, Y., Siddiq, A., García‐Closas, M., Chatterjee, N., Prokunina‐Olsson, L., Cortessis, V. K., Kooperberg, C. L., Cussenot, O., Benhamou, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt519 · Cited by 159
Liu, Y., Holdbrooks, A. T., Sarno, P. D., Rowse, A. L., Yanagisawa, L. L., McFarland, B. C., Harrington, L. E., Raman, C., Sabbaj, S., Benveniste, E. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301513 · Cited by 155
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
Guire, C. M., Prinz, M., Beyaert, R., & Loo, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.001 · Cited by 160
Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability
Lagou, V., Mägi, R., Hottenga, J., Grallert, H., Perry, J. R. B., Bouatia‐Naji, N., Marullo, L., Rybin, D. V., Jansen, R., Min, J. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-19366-9 · Cited by 157
Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways
Rosenthal, S. L., & Kamboh, M. I. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0034-x · Cited by 162
Environmental factors in autoimmune diseases and their role in multiple sclerosis
Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 156
Anti‐ LGI1 encephalitis is strongly associated with HLA‐DR7 and HLA‐DRB4
van Sonderen, A., Roelen, D. L., Stoop, J., Verdijk, R. M., Haasnoot, G. W., Thijs, R. D., Wirtz, P. W., Schreurs, M. W. J., Claas, F. H. J., Smitt, P. A. E. S., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24858 · Cited by 152
Johansson, Å., Rask‐Andersen, M., Karlsson, T., & Ek, W. E. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz175 · Cited by 155
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency
Afzali, B., Grönholm, J., Vandrovcová, J., O'Brien, C., Sun, H., Vanderleyden, I., Davis, F. P., Khoder, A., Zhang, Y., Hegazy, A. N., et al. (2017) · Nature Immunology · doi:10.1038/ni.3753 · Cited by 154
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds359 · Cited by 150
Hadgkiss, E. J., Jelinek, G. A., Weiland, T. J., Pereira, N. G., Marck, C. H., & van der Meer, D. M. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000117 · Cited by 156
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity
Lundström, W., Highfill, S. L., Walsh, S. T. R., Beq, S., Morse, E., Kockum, I. S., Alfredsson, L. S., Olsson, T. P., Hillert, J. A., & Mackall, C. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222303110 · Cited by 159
Microbial view of central nervous system autoimmunity
Berer, K., & Krishnamoorthy, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.007 · Cited by 153
Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Zhou, Y., Cui, C., Ma, X., Luo, W., Zheng, S. G., & Qiu, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00391 · Cited by 152
Seven newly identified loci for autoimmune thyroid disease
Cooper, J. D., Simmonds, M. J., Walker, N. M., Burren, O. S., Brand, O. J., Guo, H., Wallace, C., Stevens, H. E., Coleman, G., Franklyn, J. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds357 · Cited by 149
Alterations of host-gut microbiome interactions in multiple sclerosis
Cantoni, C., Lin, Q., Dorsett, Y., Ghezzi, L., Liu, Z., Pan, Y., Chen, K., Han, Y., Li, Z., Xiao, H., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103798 · Cited by 155
HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
Ollila, H. M., Ravel, J., Han, F., Faraco, J. H., Lin, L., Zheng, X., Plazzi, G., Dauvilliers, Y. A., Pizza, F., Hong, S., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.12.010 · Cited by 154
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
Thomas, O. G., Bronge, M., Tengvall, K., Akpinar, B., Nilsson, O. B., Holmgren, E., Hessa, T., Gafvelin, G., Khademi, M., Alfredsson, L. S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg3032 · Cited by 148
Naitza, S., Porcu, E., Steri, M., Taub, D. D., Mulas, A., Xiao, X., Strait, J., Dei, M., Lai, S., Busonero, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002480 · Cited by 151
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G., & Wu, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0221-5 · Cited by 148
Progress and promise in understanding the genetic basis of common diseases
Price, A. L., Spencer, C. C. A., & Donnelly, P. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2015.1684 · Cited by 147
The physiology of foamy phagocytes in multiple sclerosis
Grajchen, E., Hendriks, J. J. A., & Bogie, J. F. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0628-8 · Cited by 160
Zinc: An underappreciated modulatory factor of brain function
Marger, L., Schubert, C. R., & Bertrand, D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.002 · Cited by 150
Ma, W.-T., Chang, C. C.-C., Gershwin, M. E., & Lian, Z. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.003 · Cited by 146
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
Mallucci, G., Peruzzotti‐Jametti, L., Bernstock, J. D., & Pluchino, S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.003 · Cited by 153
Kumar, V., Wijmenga, C., & Withoff, S. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0312-1 · Cited by 145
Amato, M. P., Derfuss, T. J., Hemmer, B., Liblau, R., Montalbán, X., Sørensen, P. S., Miller, D. H., For the 2016 ECTRIMS Focused Workshop Group, Alfredsson, L. S., Aloisi, F., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516686847 · Cited by 152
Evidence-based update on rosacea comorbidities and their common physiologic pathways
Holmes, A. D., Spoendlin, J., Chien, A. L.-L., Baldwin, H. E., & Chang, A. L. S. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.07.055 · Cited by 145
Zivadinov, R., Guan, Y., Jakimovski, D., Ramanathan, M. K., & Weinstock‐Guttman, B. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.245462 · Cited by 150
Updating the mild encephalitis hypothesis of schizophrenia
Bechter, K. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.019 · Cited by 146
Berger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Weiland, T. J., Jelinek, G. A., Marck, C. H., Hadgkiss, E. J., van der Meer, D. M., Pereira, N. G., & Taylor, K. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115541 · Cited by 146
Genetic Epidemiology of Psoriasis
Gupta, R., Debbaneh, M. G., & Liao, W. J. (2014) · Current Dermatology Reports · doi:10.1007/s13671-013-0066-6 · Cited by 141
Epigenetic changes in patients with multiple sclerosis
Koch, M. W., Metz, L. M., & Kovalchuk, O. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.226 · Cited by 142
Parks, T., Mirabel, M., Kado, J. H., Auckland, K., Nowak, J., Rautanen, A., Mentzer, A. J., Marijon, É., Jouven, X., Perman, M. L., et al. (2017) · Nature Communications · doi:10.1038/ncomms14946 · Cited by 142
Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses
Bakker, O. B., Aguirre‐Gamboa, R., Sanna, S., Oosting, M., Smeekens, S. P., Jaeger, M., Zorro, M. M., Võsa, U., Withoff, S., Netea-Maier, R. T., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0121-3 · Cited by 141
Shen, K., Reichelt, M., Kyauk, R. V., Ngu, H., Shen, Y.-A. A., Foreman, O., Modrusan, Z., Friedman, B. A., Sheng, M., & Yuen, T. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108835 · Cited by 138
Our Conflict with Transposable Elements and Its Implications for Human Disease
Burns, K. H. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032633 · Cited by 137
Neutrophils Amplify Autoimmune Central Nervous System Infiltrates by Maturing Local APCs
Steinbach, K., Piédavent, M., Bauer, S., Neumann, F., & Friese, M. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202613 · Cited by 137
Auer, P. L., Teumer, A., Schick, U. M., O'Shaughnessy, A., Lo, K. S., Chami, N., Carlson, C., de Denus, S., Dubé, M., Haessler, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2962 · Cited by 141
The role of transcription factors in shaping regulatory T cell identity
Trujillo-Ochoa, J. L., Kazemian, M., & Afzali, B. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00893-7 · Cited by 142
Genome-wide Association Studies: Findings at the Major Histocompatibility Complex Locus in Psychosis
Corvin, A. P., & Morris, D. W. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.018 · Cited by 136
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data
O’Gorman, C., Lin, R., Stankovich, J., & Broadley, S. (2012) · Neuroepidemiology · doi:10.1159/000341902 · Cited by 135
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
Vermersch, P., Benrabah, R., Schmidt, N., Zéphir, H., Clavelou, P., Vongsouthi, C., Dubreuil, P. C., Moussy, A., & Hermine, O. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-36 · Cited by 135
Differential microRNA expression in blood in multiple sclerosis
Søndergaard, H. B., Hesse, D., Krakauer, M., Sørensen, P. S., & Sellebjerg, F. T. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513490542 · Cited by 134
Role of Pathogens in Multiple Sclerosis
Libbey, J. E., Cusick, M. F., & Fujinami, R. S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.823422 · Cited by 136
Smolders, J., Schuurman, K. G., van Strien, M. E., Melief, J., Hendrickx, D. A. E., Hol, E. M., van Eden, C. G., Luchetti, S., & Huitinga, I. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827f4fcc · Cited by 132
Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation
Holmdahl, R., Sareila, O., Olsson, L. M., Bäckdahl, L., & Wing, K. (2016) · Immunological Reviews · doi:10.1111/imr.12378 · Cited by 131
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis
Haider, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/725370 · Cited by 141
Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis
Graves, M. C., Benton, M. C., Lea, R. A., Boyle, M., Tajouri, L., Macartney-Coxson, D. P., Scott, R. J., & Lechner‐Scott, J. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513516529 · Cited by 131
Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis
Ishigaki, K., Kochi, Y., Suzuki, A., Tsuchida, Y., Tsuchiya, H., Sumitomo, S., Yamaguchi, K., Nagafuchi, Y., Nakachi, S., Kato, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3885 · Cited by 133
Fortune, M. D., Guo, H., Burren, O. S., Schofield, E. C., Walker, N. M., Ban, M., Sawcer, S. J., Bowes, J., Worthington, J., Barton, A. C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3330 · Cited by 130
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
Raveney, B. J. E., Oki, S., Hohjoh, H., Nakamura, M., Sato, W., Murata, M., & Yamamura, T. (2015) · Nature Communications · doi:10.1038/ncomms9437 · Cited by 134
BACH transcription factors in innate and adaptive immunity
Igarashi, K., Kurosaki, T., & Roychoudhuri, R. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.26 · Cited by 132
Long COVID or post COVID-19 syndrome
Lechner‐Scott, J., Levy, M., Hawkes, C. H., Yeh, E. A., & Giovannoni, G. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103268 · Cited by 138
XWAS: A Software Toolset for Genetic Data Analysis and Association Studies of the X Chromosome
Gao, F., Chang, D., Biddanda, A., Ma, L., Guo, Y., Zhou, Z., & Keinan, A. (2015) · Journal of Heredity · doi:10.1093/jhered/esv059 · Cited by 131
Nimmagadda, V. K. C., Bever, C. T., Vattikunta, N. R., Talat, S., Ahmad, V., Nagalla, N. K., Trisler, D. N., Judge, S. I. V., Royal, W., Chandrasekaran, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202584 · Cited by 131
Karnes, J. H., Bastarache, L., Shaffer, C. M., Gaudieri, S., Xu, Y., Glazer, A. M., Mosley, J. D., Zhao, S., Raychaudhuri, S., Mallal, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8708 · Cited by 126
Kuiper, J. J. W., van Setten, J., Ripke, S., Slot, R. V. ‘., Mulder, F., Missotten, T., Baarsma, G. S., Francioli, L. C., Pulit, S. L., de Kovel, C. G. F., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu307 · Cited by 131
The role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 130
The regulatory power of glycans and their binding partners in immunity
Johnson, J. L., Jones, M. B., Ryan, S. O., & Cobb, B. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.006 · Cited by 131
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage
Croxford, A. L., Spath, S., & Becher, B. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.004 · Cited by 132
Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation
Do, C., Lang, C. F., Lin, J. P., Darbary, H. K., Krupska, I., Gaba, A., Petukhova, L., Vonsattel, J., GALLAGHER, M. P., Goland, R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.027 · Cited by 130
Metadata
- Authors
- The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7359
- Pages
- 214-219
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3182531
- OpenAlex
- W2040547343
- Cited by
- 2,697
- References
- 26
- Citations by year
- 2026: 72 · 2025: 101 · 2024: 112 · 2023: 111 · 2022: 136 · 2021: 155 · 2020: 167 · 2019: 173 · 2018: 178 · 2017: 215 · 2016: 220 · 2015: 273 · 2014: 244 · 2013: 279 · 2012: 223
- FWCI
- 175.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Keele Research Repository (Keele University) (submittedVersion, cc-by)
- PEARL (University of Plymouth) (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Murdoch University Research Portal (submittedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Griffith Research Online (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Susan G. Komen for the Cure
- Biogen
- Kaiser Permanente
- Children's Hospital of Philadelphia
- Fondazione CRT
- Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
- Institute of Clinical and Translational Sciences
- Scleroseforeningen
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Wellcome Trust (085475/Z/08/Z, 068545/Z/02), 085475, G0000934, 075491, 068545, 075491/Z/04,, 090532, 085475/B/08/Z, 084702)
- National Institute for Health and Care Research (G0000934, NF-SI-0507-10379, PDA/02/06/016)
- Parkinson's UK (G0909, J‐0804)
- Multiple Sclerosis Society (898/08)
- Multiple Sclerosis Australia
- Deutsche Forschungsgemeinschaft
- Agence Nationale de la Recherche (ANR-10-INBS-0001)
- Institut National de la Santé et de la Recherche Médicale
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Academy of Finland
- Fonds Wetenschappelijk Onderzoek
- Ministero della Salute (502/92, D.lgs 502/92)
- Hjärnfonden
- Knut och Alice Wallenbergs Stiftelse
- Stockholms Läns Landsting (562183)
- Norges Forskningsråd
- Regione Piemonte (502/92)
- Haukeland Universitetssjukehus
- Vlaamse regering
- National Institutes of Health (5r01ns019142-03, G0000934, 075491/Z/04, 068545/Z/02, UL1TR000448, NS43559, NS19142, RR024992, CA104021, NS049477)
- U.S. Public Health Service (K23N/S048869)
- Medical Research Council (MC_EX_G0800860, 068545/Z/02, G0000934)
- National Health and Medical Research Council (G0000934)
- Helmholtz Zentrum München
- National Cancer Institute (R01CA104021, CA104021)
- National Institute of Allergy and Infectious Diseases (AI076544, R01AI076544)
- Fogarty International Center (K01TW009996)
- National Institute of Neurological Disorders and Stroke (NS067305, NS26799, NS 43559, NS032830, NS049477, NS19142, R01NS032830, R01NS043559, R01NS026799, R01NS049510, R01NS067305, NS049510, R01NS049477)
- National Center for Research Resources (RR020092, C06RR020092, RR-024992, UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, genome-wide association study, major histocompatibility complex, T helper cell differentiation, cell-mediated immunity, neuroinflammation, neurodegeneration, pathogenesis, genetic susceptibility loci
- MeSH terms
- Alleles, Cell Differentiation, Europe, T-Lymphocytes, Helper-Inducer, HLA-DR Antigens, Humans, Immunity, Cellular, Major Histocompatibility Complex, Multiple Sclerosis, HLA-A Antigens, Genome, Human, Sample Size, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
